Found 80 matching trials
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors PHASE1 This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Personalised Disease Monitoring in Metastatic Breast Cancer N/A Patients with metastatic breast cancer may respond well to treatment and me...
Show More Status
Active Not Recruiting
Location
Department of Oncology, Sahlgrenska University Hospital
Learn More & Join Trial
Gastrointestinal Motility Among Diabetes Patients NA Gastrointestinal (GI) symptoms including vomiting, nausea, abdominal pain, ...
Show More Location
Department of Hepatology and Gastroenterology, Aarhus University Hospital
Learn More & Join Trial
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer PHASE2 This research study is studying a combination of targeted therapies as a po...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor PHASE3 This is a prospective, randomized, open-label, multicenter phase III study ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): PHASE3 This was a randomized, double-blind, placebo-controlled, global, multicente...
Show More Location
AZ Oncology Associates - HOPE
Learn More & Join Trial
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer PHASE2 This phase II trial studies how well a vaccine, STEMVAC, works in combinati...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer PHASE1 This is a dose-escalation Phase Ib clinical trial in 18 patients with newly...
Show More Location
California Research Institute
Learn More & Join Trial
TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma PHASE2 A clinical trial evaluating TQB3616 capsules versus placebo in the treatmen...
Show More Location
Peking University First Hospital
Learn More & Join Trial